In the Margins

Carlyle: Travelers CEO steps off board to fight illness

October 28, 2015

By Bloomberg

Carlyle Group LP said Travelers Cos. CEO Jay Fishman stepped down from its board while fighting amyotrophic lateral sclerosis, or ALS. Fishman, 62, said in August he would be replaced as Travelers CEO on Dec. 1 by Alan Schnitzer and stay on as executive chairman. Anthony Welters, executive chairman of investment company Black Ivy Group and a senior adviser to the office of the CEO at UnitedHealth Group Inc., has joined the Carlyle board as independent director. Read the original story from Bloomberg.

 

 

Most Read

A Seat at the Table
Invesco Funds board finalizes succession plans

The Invesco Funds board will name Christopher Wilson vice chairman at its June meeting, making him the heir apparent to long-serving independent Chair Bruce Crockett. Crockett ...

Top of the Agenda - Compensation
Fund board comp moves up, as industry keeps changing

Analyzing mutual fund director compensation data is getting increasingly difficult as consolidation reshapes the mid-sized to large end of the market and a reduction in stand-alone ...

Top of the Agenda - Industry Groups
IDC's Amy Lancellotta to retire at year-end

Amy Lancellotta will retire from the Independent Directors Council at the end of this year after 13 years as managing director and a total of 30 ...